Marker lesion study of oral erdafitinib in patients with intermediate-risk non-muscle–invasive bladder cancer with fgfr3/2 alterations in thor-2: updated cohort 3 results

Siamak Daneshmand, Renata Zaucha,Nikhil Vasdev, Benjamin A Gartrell,Yair Lotan,Syed A Hussain, Eugene K Lee,Giuseppe Procopio, Fernando Galanternik,Geraldine Pignot,Debasish Sundi, Hernan J Cutuli, Lauren Crow,Vahid Naini,Spyros Triantos, Mahadi Baig,Jodi K Maranchie

Urologic Oncology: Seminars and Original Investigations(2024)

引用 0|浏览2
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要